Examining the Relationship Between Ongoing Alcohol Use, Suicidal Thoughts and Behaviors and Related Constructs, and Behavioral Economic Decision-Making
Launched by MARK J RZESZUTEK, PHD · Feb 19, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how ongoing alcohol use is related to thoughts and behaviors about suicide, as well as how people make decisions about their drinking. The study will involve 100 adults, aged 18 and older, who drink alcohol regularly and have some interest in cutting back or quitting. Researchers want to find out what factors might predict these thoughts and behaviors, and how effective a remote computer-based training program (called CBT4CBT) can be in helping participants with their alcohol use and mental health.
If you are interested in participating, you need to be at least 18 years old and drink alcohol at least once a week. You should have a specific score on a test that checks for alcohol use issues, indicating you might benefit from help. Participants will start with an assessment and then have access to online training modules over three months, where they will also complete follow-up assessments. The goal is to understand better how alcohol use affects mental health and how effective the online program is for those looking to change their drinking habits.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • At least 18 years old
- • Consume alcohol at least weekly
- • A score of 8 or greater on the Alcohol Use Disorder Identification Test (AUDIT)
- • Some interest in cutting back on drinking or quitting
- • Read and understand English
- Exclusion Criteria:
- • A score of 31 or greater on the Alcohol Use Disorder Identification Test (AUDIT) at baseline
- • Reporting schizophrenia and/or other psychiatric diagnoses other than depression or anxiety at baseline
- • Already being in treatment for alcohol use disorder at baseline
- • Past month substance use other than cannabis or tobacco
About Mark J Rzeszutek, Phd
Mark J. Rzeszutek, PhD, is a distinguished clinical trial sponsor known for his commitment to advancing medical research and improving patient outcomes. With a strong background in biomedical sciences and extensive experience in trial design and implementation, Dr. Rzeszutek leads innovative studies that focus on the development of novel therapeutics and treatment strategies. His expertise encompasses various therapeutic areas, and he is dedicated to ensuring rigorous ethical standards and regulatory compliance throughout the research process. Dr. Rzeszutek's collaborative approach fosters partnerships with academic institutions and industry leaders, driving forward the mission to translate scientific discoveries into real-world applications.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lexington, Kentucky, United States
Patients applied
Trial Officials
Mark J Rzeszutek, PhD
Principal Investigator
University of Kentucky
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported